These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 20211907)

  • 1. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy.
    Montes J; McDermott MP; Martens WB; Dunaway S; Glanzman AM; Riley S; Quigley J; Montgomery MJ; Sproule D; Tawil R; Chung WK; Darras BT; De Vivo DC; Kaufmann P; Finkel RS;
    Neurology; 2010 Mar; 74(10):833-8. PubMed ID: 20211907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue leads to gait changes in spinal muscular atrophy.
    Montes J; Dunaway S; Montgomery MJ; Sproule D; Kaufmann P; De Vivo DC; Rao AK
    Muscle Nerve; 2011 Apr; 43(4):485-8. PubMed ID: 21404286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-minute walk test is reliable and valid in spinal muscular atrophy.
    Dunaway Young S; Montes J; Kramer SS; Marra J; Salazar R; Cruz R; Chiriboga CA; Garber CE; De Vivo DC
    Muscle Nerve; 2016 Nov; 54(5):836-842. PubMed ID: 27015431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leg muscle function and fatigue during walking in spinal muscular atrophy type 3.
    Montes J; Dunaway S; Garber CE; Chiriboga CA; De Vivo DC; Rao AK
    Muscle Nerve; 2014 Jul; 50(1):34-9. PubMed ID: 24122959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the timed "up & go" test in spinal muscular atrophy.
    Dunaway S; Montes J; Garber CE; Carr B; Kramer SS; Kamil-Rosenberg S; Strauss N; Sproule D; De Vivo DC
    Muscle Nerve; 2014 Aug; 50(2):273-7. PubMed ID: 24375426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen.
    Govoni A; Ricci G; Bonanno S; Bello L; Magri F; Meneri M; Torri F; Caponnetto C; Passamano L; Grandis M; Trojsi F; Cerri F; Gadaleta G; Capece G; Caumo L; Tanel R; Saccani E; Vacchiano V; Sorarù G; D'Errico E; Tramacere I; Bortolani S; Rolle E; Gellera C; Zanin R; Silvestrini M; Politano L; Schenone A; Previtali SC; Berardinelli A; Turri M; Verriello L; Coccia M; Mantegazza R; Liguori R; Filosto M; Maioli MA; Simone IL; Mongini T; Corti S; Manca ML; Pegoraro E; Siciliano G; Comi GP; Maggi L
    Muscle Nerve; 2024 Oct; 70(4):816-823. PubMed ID: 39096012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
    Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory function in spinal muscular atrophy: Age-related patterns of progression.
    Montes J; McDermott MP; Mirek E; Mazzone ES; Main M; Glanzman AM; Duong T; Young SD; Salazar R; Pasternak A; Gee R; De Sanctis R; Coratti G; Forcina N; Fanelli L; Ramsey D; Milev E; Civitello M; Pane M; Pera MC; Scoto M; Day JW; Tennekoon G; Finkel RS; Darras BT; Muntoni F; De Vivo DC; Mercuri E
    PLoS One; 2018; 13(6):e0199657. PubMed ID: 29944707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6MWT can identify type 3 SMA patients with neuromuscular junction dysfunction.
    Pera MC; Luigetti M; Pane M; Coratti G; Forcina N; Fanelli L; Mazzone ES; Antonaci L; Lapenta L; Palermo C; Ranalli D; Granata G; Lomonaco M; Servidei S; Mercuri E
    Neuromuscul Disord; 2017 Oct; 27(10):879-882. PubMed ID: 28803817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophy.
    Montes J; Dunaway Young S; Mazzone ES; Pasternak A; Glanzman AM; Finkel RS; Darras BT; Muntoni F; Mercuri E; De Vivo DC; Bishop KM; Schneider E; Bennett CF; Foster R; Farwell W;
    Muscle Nerve; 2019 Oct; 60(4):409-414. PubMed ID: 31298747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of Fatigability in Patients With Spinal Muscular Atrophy.
    Bartels B; de Groot JF; Habets LE; Wadman RI; Asselman FL; Nieuwenhuis EES; van Eijk RPA; Goedee HS; van der Pol WL
    Neurology; 2021 Feb; 96(6):e845-e852. PubMed ID: 33219141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect on ambulation of dalfampridine-ER (4-AP) treatment in adult SMA patients.
    Chiriboga CA; Marra J; LaMarca NM; Young SD; Weimer LH; Levin B; McCabe B
    Neuromuscul Disord; 2020 Aug; 30(8):693-700. PubMed ID: 32788051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.
    Montes J; Glanzman AM; Mazzone ES; Martens WB; Dunaway S; Pasternak A; Riley SO; Quigley J; Pandya S; De Vivo DC; Kaufmann P; Chiriboga CA; Finkel RS; Tennekoon GI; Darras BT; Pane M; Mercuri E; Mcdermott MP;
    Muscle Nerve; 2015 Dec; 52(6):942-7. PubMed ID: 25846132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis.
    Hagenacker T; Maggi L; Coratti G; Youn B; Raynaud S; Paradis AD; Mercuri E
    Neurol Ther; 2024 Oct; 13(5):1483-1504. PubMed ID: 39222296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Assessment of Timed Function Tests in Ambulatory Individuals with SMA Treated with Nusinersen.
    Krosschell KJ; Brown L; Hoffman K; Zumpf KB; Munson H; Bidwell J; Schulte DP; Schwaede AN; Buehner AN; DiDonato CJ; Kuntz NL; Rao VK
    J Neuromuscul Dis; 2023; 10(3):337-348. PubMed ID: 36872785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of step length on 6-minute walk test performance in patients with chronic heart failure.
    Pepera GK; Sandercock GR; Sloan R; Cleland JJ; Ingle L; Clark AL
    Physiotherapy; 2012 Dec; 98(4):325-9. PubMed ID: 23122439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weakness and fatigue in diverse neuromuscular diseases.
    Montes J; Blumenschine M; Dunaway S; Alter AS; Engelstad K; Rao AK; Chiriboga CA; Sproule DM; De Vivo DC
    J Child Neurol; 2013 Oct; 28(10):1277-83. PubMed ID: 23847297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy.
    Montes J; Goodwin AM; McDermott MP; Uher D; Hernandez FM; Coutts K; Cocchi J; Hauschildt M; Cornett KM; Rao AK; Monani UR; Ewing Garber C; De Vivo DC
    Ann Clin Transl Neurol; 2021 May; 8(5):1086-1095. PubMed ID: 33788421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy.
    Rodriguez-Torres R; Fabiano J; Goodwin A; Rao AK; Kinirons S; De Vivo D; Montes J
    J Neuromuscul Dis; 2020; 7(4):459-466. PubMed ID: 32925091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived exertion is not a substitute for fatiguability in spinal muscular atrophy.
    Cheng R; Feng J; Goodwin AM; Uher D; Rao AK; McDermott MP; De Vivo DC; Ewing Garber C; Montes J
    Muscle Nerve; 2023 Jul; 68(1):81-84. PubMed ID: 36484158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.